Nano-X AI
About Nano-X AI
Nano-X Imaging Ltd. (NASDAQ: NNOX), often referred to as Nanox, is a medical imaging technology company dedicated to increasing the accessibility and affordability of diagnostic medicine globally. The company’s integrated, end-to-end platform combines innovative hardware with advanced artificial intelligence (AI) solutions and cloud-based services. At its core is the Nanox.ARC, an FDA-cleared and CE-marked multi-source digital tomosynthesis imaging system designed for cost-effective, high-resolution 3D imaging, aiming to expand medical imaging capabilities both within and beyond traditional hospital settings.
Nanox.AI, a key subsidiary, develops a suite of FDA-cleared AI-based algorithms that augment the interpretation of routine CT imaging. These solutions are designed to identify early signs of prevalent chronic diseases that might otherwise go unnoticed. For instance, HealthCCSng detects coronary artery calcium, an indicator of coronary artery disease; HealthOST assesses bone mineral density and identifies vertebral compression fractures, key warning signs of osteoporosis; and HealthFLD measures liver density, which can indicate fatty liver disease. By integrating these AI-driven insights into clinical workflows, Nanox.AI aims to empower physicians with actionable information, facilitate earlier detection, and enable the establishment of preventative care pathways, ultimately enhancing patient outcomes and improving clinical efficiency.
The Nanox ecosystem further includes Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics, and Nanox.MARKETPLACE (through its subsidiary USARAD Holdings Inc.), which provides access to remote radiology and cardiology experts and comprehensive teleradiology services. This comprehensive approach, integrating imaging technology, AI, cloud infrastructure, and clinical expertise, seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
Focus Areas
Business Intelligence
| Key Investors | BlackRock, State Street Corp, UBS Group AG, ARK Investment Management LLC, SK Telecom, Foxconn, Yozma Korea, Industrial Alliance |
| Partnerships | 3DR Labs, Ferrum Health, Nuance Precision Imaging Network, Monarch Medical Management and Billing LLC |
| Acquisitions | Nano-X AI (formerly Zebra Medical Vision LTD) in 2021, USARAD Holdings Inc., MDWEB, LLC, VasoHealthcare IT in 2025 |
| Technology | AI-based suite of algorithms, cloud-native (Nanox.CLOUD), leverages routine CT imaging data, digital X-ray source technology (Nanox.ARC ecosystem) |
| FDA Clearances | 3 (HealthCCSng, HealthOST, HealthFLD for AI solutions) cleared products (estimated) |
What Physicians Need to Know
Nano-X AI offers physicians a powerful tool to enhance diagnostic capabilities by leveraging existing CT scans for opportunistic screening of chronic diseases. The FDA-cleared solutions (HealthFLD, HealthCCSng, HealthOST) provide actionable insights, such as quantifying coronary artery calcification or identifying vertebral compression fractures, which can be seamlessly integrated into radiology reports. This enables earlier detection of often asymptomatic conditions, facilitating timely interventions and preventive care pathways. The automated analysis minimizes additional workload, while potentially improving patient outcomes, reducing critical events, and supporting value-based care models through more accurate risk adjustment and CPT code utilization.
Nano-X AI solutions are designed for seamless integration with existing Picture Archiving and Communication Systems (PACS). They also connect to the Nuance Precision Imaging Network and are integrated into Nanox's Second Opinions online medical consultation service (a USARAD subsidiary), providing a comprehensive and connected ecosystem for medical imaging and AI-powered analytics.
What the Web Says
Nano-X AI, a subsidiary of Nano-X Imaging, focuses on developing AI solutions for medical imaging, particularly for early detection of chronic diseases from routine CT scans. The company's core product, Nanox.AI, offers solutions like HealthCCSng for cardiac conditions, HealthOST for bone density and fractures, and HealthFLD for fatty liver disease. While the technology shows promise in improving early diagnosis and preventative care, the company faces challenges in scaling its operations and achieving profitability. There's also some skepticism regarding the initial marketing hype surrounding its imaging technology.
Overall: MixedStrengths
- AI-powered solutions for early detection of chronic diseases from routine CT scans.
- Potential to improve patient outcomes and reduce healthcare burden through earlier diagnosis.
- FDA-cleared AI solutions.
- Cost-effective alternative to traditional X-ray machines with the Nanox.ARC system.
- Strong potential for market disruption with novel X-ray tube technology.
- Proven value in increasing detection of coronary calcification and spine fractures.
Limitations
- Skepticism and concerns about initial marketing hype and product demonstrations.
- Slow execution and deployment of imaging systems.
- Challenges in converting technological foundations into substantial revenue.
- Negative cash flow from operations and potential need for additional financing.
- Underdeveloped investor outreach and marketing.
- Some Reddit discussions express concerns about the company's stock and past rumors.
Based on reviews from: Reddit, AuntMinnie, G2, Seeking Alpha, Indeed.com
Last updated: 2026-07-18
Videos
News, demos, and interviews about Nano-X AI.
Videos load interactively. If none appear, search YouTube for Nano-X AI →
Press & Coverage
Frequently Asked Questions
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]